FOXO TECHNOLOGIES INC. Weighted Average Basic Shares Outstanding, Pro Forma
FOXO TECHNOLOGIES INC. (FOXO) reported Weighted Average Basic Shares Outstanding, Pro Forma of 1.51 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageBasicSharesOutstandingProForma · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. weighted average basic shares outstanding, pro forma for the quarter ending 2026-03-31 was 1.51M shares.
- FOXO TECHNOLOGIES INC. weighted average basic shares outstanding, pro forma for the quarter ending 2025-06-30 was 1.51K shares.
- FOXO TECHNOLOGIES INC. weighted average basic shares outstanding, pro forma for fiscal 2025 was 264.83M shares, a 33452.75% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. weighted average basic shares outstanding, pro forma for fiscal 2024 was 789.30K shares, a 84.94% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. weighted average basic shares outstanding, pro forma for fiscal 2023 was 5.24M shares.
| Period end | Weighted Average Basic Shares Outstanding, Pro Forma 3 month | Weighted Average Basic Shares Outstanding, Pro Forma 6 month | Weighted Average Basic Shares Outstanding, Pro Forma 12 month | Weighted Average Basic Shares Outstanding, Pro Forma 12 month as first filed |
|---|---|---|---|---|
| 2026-03-31 | 1.51M shares 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | 264.83M shares 10-K · filed 2026-04-15 | |||
| 2025-06-30 | 1.51K shares 10-Q · filed 2026-08-14 | 1.01K shares 10-Q · filed 2026-08-14 | ||
| 2024-12-31 | 789.30K shares 10-K · filed 2026-04-15 | 15.17M shares 10-K · filed 2025-04-15 | ||
| 2023-12-31 | 5.24M shares 10-K · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |